Medication info

Zinc Injection (Zinc Sulfate Hydrate)

Prescription medicationInjections
Ingredient · strength
Zinc Sulfate Hydrate›4.4mg / 1mL
Manufacturer / importer
Daehan Pharmaceutical Co., Ltd.
Appearance
A colorless, odorless, transparent liquid in a colorless and transparent vial injection.
Packaging
10mL, 15mL, 20mL/vial × 10
Approval status
Active

MFDS item code 201504712 · Notified 2015.07.09

Summary

Main use
Prevention of zinc deficiency during total parenteral nutrition (TPN)
Who uses it
Adults · Children
Adult dosage
Metabolically stable patients receiving TPN: 2.5 ∼ 4 mg/day Adult patients with small-intestinal fluid loss: an additional 12.2 mg/L (volume of fluid lost) or an additional 17.1 mg/kg (amount excreted) Acute catabolic state: 4.5 ∼ 6 mg/day Use as prescribed by a physician. Check plasma trace element levels and use them as a guide for dose adjustment.
Children's dosage
Children 5 years and under: 100 ug/kg/day Premature infants weighing 3 kg or less: 300 ug/kg/day

Ingredients

Manufacturer
Daehan Pharmaceutical Co., Ltd.

Efficacy & effects

Prevention of zinc deficiency during total parenteral nutrition (TPN)

View approved original text

Patients receiving Total Parenteral Nutrition (TPN) may become deficient in zinc, therefore zinc supplementation is necessary. Zinc is an important mineral that strengthens immune function and aids in wound healing. Thus, appropriate zinc supplementation through TPN improves nutritional status.

Dosage and Administration

Adult dosage

Metabolically stable patients receiving TPN: 2.5 ∼ 4 mg/day Adult patients with small-intestinal fluid loss: an additional 12.2 mg/L (volume of fluid lost) or an additional 17.1 mg/kg (amount excreted) Acute catabolic state: 4.5 ∼ 6 mg/day Use as prescribed by a physician. Check plasma trace element levels and use them as a guide for dose adjustment.

Children's dosage

Children 5 years and under: 100 ug/kg/day Premature infants weighing 3 kg or less: 300 ug/kg/day

Precautions

This medication should not be administered directly into the peripheral vein without dilution. Direct administration into the peripheral vein may lead to phlebitis and increases the risk of kidney damage due to rapid intravenous injection. The amount of zinc in this preparation is very small, so toxic symptoms are generally rarely observed. When mixing this medication with other nutritional infusions, it is advisable to prepare it in a laminar flow environment to maintain sterility. It is essential to visually check for any precipitation or discoloration before administering non-oral medications. Zinc and copper affect each other; therefore, administering zinc may lower plasma copper levels. It is necessary to monitor zinc and copper levels through blood tests at regular intervals. This medication is primarily excreted through the intestines and kidneys, so patients with impaired excretion should consider the possibility of zinc accumulation in the body. When administering this medication to pregnant women or women of childbearing potential, it should only be used when the benefits of treatment outweigh the risks. Zinc crosses the placenta and can be found in breast milk, so caution is also needed for breastfeeding women. Excessive intake of zinc can lead to symptoms such as nausea, vomiting, dehydration, electrolyte imbalance, dizziness, abdominal pain, drowsiness, and coordination difficulties, which can be life-threatening in severe cases. Calcium intake may help reduce zinc toxicity. This medication should be stored out of reach of children, and it is recommended to keep it in a dry state at room temperature in its original packaging. Additionally, since this medication does not contain preservatives, any unused portion must be discarded.

Side effects

  • Phlebitis
  • increased renal loss of zinc
  • nausea
  • vomiting
  • dehydration
  • electrolyte imbalance
  • dizziness
  • abdominal pain
  • lethargy
  • ataxia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to prevent contact with air and it is recommended to be kept at a temperature between 1°C and 30°C. Storing it this way will help maintain the effectiveness of the medication.

Appearance and packaging

Appearance

A colorless, odorless, transparent liquid in a colorless and transparent vial injection.

Package unit

10mL, 15mL, 20mL/vial × 10

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.